Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Systematic Reviews
Published in: Systematic Reviews 1/2017

Open Access 01-12-2017 | Protocol

Ecological validity of cost-effectiveness models of universal HPV vaccination: a protocol for a systematic review

Authors: Giampiero Favato, Emmanouil Noikokyris, Riccardo Vecchiato

Published in: Systematic Reviews | Issue 1/2017

Login to get access

Abstract

Background

Sexually transmitted infection with high-risk, oncogenic strains of human papillomavirus (HPV) still induces a relevant burden of diseases on both men and women. Although vaccines appear to be highly efficacious in preventing the infection of the most common high-risk strains (HPV 6, 11, 16, 18), important questions regarding the appropriate target population for prophylactic vaccination are still debated. Models in the extant literature seem to converge on the cost-effectiveness of high coverage (>80%) of a single cohort of 12-year-old girls. This vaccination strategy should provide an adequate level of indirect protection (herd immunity) to the unvaccinated boys. This argument presupposes the ecological validity of the cost-effectiveness models; the implicit condition that the characteristics of the individuals and the sexual behaviours observed in the models is generalisable to the natural behaviours of the population.
The primary aim of this review is to test the ecological validity of the cost-effectiveness models of universal HPV vaccination available in the literature. The ecological validity of each model will be defined by the number of representative characteristics and behaviours taken into consideration.

Methods

Nine bibliographic databases will be searched: MEDLINE (via PubMed); Scopus; Science Direct; EMBASE via OVID SP, Web of Science, DARE, NHIR EED and HTA (via NHIR CRD); and CINHAL Plus. An additional search for grey literature will be conducted on Google Scholar and Open Grey. A search strategy will be developed for each of the databases. Data will be extracted following a pre-determined spreadsheet and then clustered and prioritised: the main outcomes will report the inputs to the demographic and epidemiological model, while additional outcomes will refer to basic inputs to the cost-effectiveness valuation.
Each study included in the review will be scored by the number of representative characteristics and behaviours taken into consideration (yes or no) on both dimensions. Individual study’s scores will be plotted in a 2 by 2 matrix: studies included in the upper right quadrant will be defined as ecologically valid, since which both individuals’ characteristics and their sexual behaviours are representative.

Discussion

The proposed systematic review will be the first to assess the ecological validity of cost-effectiveness studies. In the context of sexually transmitted diseases, when this condition is violated, an error in predicting the protective impact of herd immunity would occur. Hence, a vaccination policy informed on ecologically invalid models would potentially expose boys to a residual risk of contracting HPV-induced malignancies.

Systematic review registration

PROSPERO CRD42016034145
Appendix
Available only for authorised users
Literature
1.
2.
3.
Newall TA, Beutels P, Wood JG, Edmunds WJ, Macintyre CR. Cost-effectiveness analyses of human papillomavirus vaccination. Lancet Infect Dis. 2007;7:289–96.CrossRefPubMed
4.
Koleva D, De Compadri P, Padula A, Garattini L. Economic evaluation of human papilloma virus vaccination in the European Union: a critical review. Intern Emerg Med. 2011;6:163–74.CrossRefPubMed
5.
Brisson M, Van de Velde N, Boily MC. Economic evaluation of human papillomavirus vaccination in developed countries. Public Health Genomics. 2009;12:343–51.CrossRefPubMed
6.
Yahia MCBH, Jouin-Bortolotti A, Dervaux B. Extending the human papillomavirus vaccination programme to include males in high-income countries: a systematic review of the cost-effectiveness studies. Clin Drug Investig. 2015;35:471–85.CrossRef
7.
Audisio RA, Icardi G, Isidori AM, Liverani CA, Lombardi A, Mariani L, et al. Public health value of universal HPV vaccination. Crit Rev Oncol/Haematol. 2015;97:157–67.CrossRef
8.
Marsh K, Chapman R, Baggaley RF, Largeron N, Bresse X. Mind the gaps: what’s missing from current economic evaluations of universal HPV vaccination? Vaccine. 2014;32:3732–9.CrossRefPubMed
9.
10.
Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. PRISMA-P Group. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;349(jan02 1):g7647.CrossRefPubMed
11.
Shmuckler MA. What is ecological validity? A dimensional analysis. Infancy. 2001;2(4):419–36.CrossRef
12.
Campbell DT. Factors relevant to validity of experiments in social settings. Psychol Bull. 1957;54:297–312.CrossRefPubMed
13.
Brunswik E. Perception and the representative design of experiments. 2nd ed. Berkeley: University of California Press; 1956.
14.
15.
Ghani AC, Garnett GP. Measuring sexual partner networks for transmission of sexually transmitted diseases. J R Statist Soc. 1998;161(2):227–38.CrossRef
16.
Garnett GP, Holmes EC. The ecology of emergent infectious disease. Bioscience. 1996;46(2):127–35.CrossRef
17.
Fenton KA, et al. Sexual behaviour in Britain: reported sexually transmitted infections and prevalent genital Chlamydia trachomatis infection. Lancet. 2001;358:1851–4.CrossRefPubMed
18.
19.
The UK Collaborative Group for HIV & STI Surveillance. Testing times. HIV and other sexually transmitted infections in the United Kingdom. London: Health Protection Agency, Centre for Infections; 2007.
20.
Morris M, Kretzschmar M. Concurrent partnerships and transmission dynamics in networks. Soc Networks. 1995;17:299–318.CrossRef
21.
Watts CH, May RM. The influence of concurrent partnerships on the dynamics of HIV/AIDS. Math Biosci. 1992;108:89–104.CrossRefPubMed
22.
Darwich L, Cañadas MP, Videla S, Coll J, Molina-López RA, Sirera G, et al. Prevalence, clearance, and incidence of human papillomavirus type–specific infection at the anal and penile site of HIV-infected men. Sex Transm Dis. 2013;40(8):611–8.CrossRefPubMed
23.
DiClemente RJ, Wingood GM, Crosby RA, Sionean C, Cobb BK, Harrington K, et al. Sexual risk behaviors associated with having older sex partners: a study of black adolescent females. Sex Transm Dis. 2002;29:20–4.CrossRefPubMed
24.
Matteelli A, Capone S. The Holy Grail of sexually transmitted infections in travellers. Sex Transm Infect. 2016;92:405–06.
25.
Jones KG, Johnson AM, Wellings K, Sonnenberg P, Field N, Tanton C, et al. The prevalence of, and factors associated with paying for sex among men resident in Britain: findings from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3). Sex Transm Infect. 2014;0:1–8.
26.
Garnett GP, Hughes JP, Anderson RM, Stoner BP, Aral SO, Whittington WL, et al. Sexual mixing patterns of patients attending sexually transmitted diseases clinics. Sex Transm Dis. 1996;23:248–57.CrossRefPubMed
27.
Aicken CRH, Gray M, Clifton S, Tanton C, Field N, Sonnenberg P, et al. Improving questions on sexual partnerships: lessons learned from cognitive interviews for Britain’s Third National Survey of Sexual Attitudes and Lifestyles (“Natsal-3”). Arch Sex Behav. 2013;42:173–85.CrossRefPubMed
28.
Mercer CH, Tanton C, Prah P, Sonnenberg P, Clifton S, Macdowall W, et al. Changes in sexual attitudes and lifestyles in Britain through the life course and over time: findings from the National Surveys of sexual Attitudes and Lifestyles (Natsal). Lancet. 2013;382(9907):1781–94.CrossRefPubMedPubMedCentral
29.
Schiller JT, Castellsagué X, Garland SM. A review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine. 2012;30 Suppl 5:F123–38.CrossRefPubMedPubMedCentral
30.
Garland SM, Kjaer SK, Muñoz N, Block SL, Brown DR, DiNubile MJ, et al. Impact and effectiveness of the quadrivalent human papillomavirus vaccine: a systematic review of 10 years of real-world experience. Clin Infect Dis. 2016. doi:10.​1093/​cid/​ciw354 [Epub ahead of print].PubMedCentral
31.
Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.CrossRefPubMedPubMedCentral
32.
Sterne JAC, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.CrossRefPubMedPubMedCentral
33.
Husereau D, Drummond M, Petrou S, Caarswell C, Moher D, Greemberg D, et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. Value Health. 2013;16(2):231–50.CrossRefPubMed
34.
Hogarth MR. The challenge of representative design in psychology and economics. J Econ Methodol. 2005;12(2):253–63.CrossRef
Metadata
Title
Ecological validity of cost-effectiveness models of universal HPV vaccination: a protocol for a systematic review
Authors
Giampiero Favato
Emmanouil Noikokyris
Riccardo Vecchiato
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Systematic Reviews / Issue 1/2017
Electronic ISSN: 2046-4053
DOI
https://doi.org/10.1186/s13643-017-0409-7

Other articles of this Issue 1/2017

Systematic Reviews 1/2017 Go to the issue

Protocol

Immediate versus delayed surgery for hip fractures in the elderly patients: a protocol for a systematic review and meta-analysis

Protocol

Mobile tablet-based therapies following stroke: a systematic scoping review protocol of attempted interventions and the challenges encountered

Protocol

The relationship between childhood body weight and dental caries experience: an umbrella systematic review protocol

Protocol

Effective knowledge translation approaches and practices in Indigenous health research: a systematic review protocol

Protocol

Behavioral interventions to promote adequate sleep among women: protocol for a systematic review and meta-analysis

Research

Quality indicators for care of depression in primary care settings: a systematic review